Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis

BACKGROUND: Vedolizumab (VDZ) is a gut-specific α4-β7 integrin antagonist that has demonstrated efficacy in Crohn’s disease (CD) and ulcerative colitis (UC). The safety of VDZ in the perioperative period remains unclear. The aim of this study was to evaluate postoperative complications and periopera...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotze, Paulo Gustavo, Ma, Christopher, Mckenna, Nicholas, Almutairdi, Abdulelah, Kaplan, Gilaad G., Raffals, Laura E., Loftus, Edward V., Panaccione, Remo, Lightner, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024272/
https://www.ncbi.nlm.nih.gov/pubmed/29977340
http://dx.doi.org/10.1177/1756284818783614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024272/
https://www.ncbi.nlm.nih.gov/pubmed/29977340
http://dx.doi.org/10.1177/1756284818783614

Ejemplares similares